EGFR and neoplasm: Additionally, the anti-tumor activity of ATR-I was diminished after KIF15 overexpression in AR+ and AR− CRPC cells, indicating that KIF15 expedited CRPC progression in both an AR-dependent- and independent manners, such as the EGFR signaling pathway.